Multiplex Assay Kit for High Mobility Group AT Hook Protein 2 (HMGA2) ,etc. by FLIA (Flow Luminescence Immunoassay)

BABL; HMGI-C; HMGIC; LIPO; High mobility group protein HMGI-C

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of High Mobility Group AT Hook Protein 2 (HMGA2) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between High Mobility Group AT Hook Protein 2 (HMGA2) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant High Mobility Group AT Hook Protein 2 (HMGA2) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of High Mobility Group AT Hook Protein 2 (HMGA2) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 98-105 102
EDTA plasma(n=5) 80-91 84
heparin plasma(n=5) 93-101 97
sodium citrate plasma(n=5) 81-94 85

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level High Mobility Group AT Hook Protein 2 (HMGA2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level High Mobility Group AT Hook Protein 2 (HMGA2) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of High Mobility Group AT Hook Protein 2 (HMGA2) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 94-101% 95-103% 93-101% 78-101%
EDTA plasma(n=5) 87-95% 94-104% 80-101% 83-96%
heparin plasma(n=5) 91-99% 81-96% 94-101% 79-104%
sodium citrate plasma(n=5) 79-91% 78-101% 80-94% 78-97%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:HMGA2) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Gastrointest Endosc Pancreatic cyst fluid concentration of high-mobility group A2 PubMed: 26408423
Gastrointest Endosc. Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm science:S0016510715029351
journal of neurosurgery MEG3/MIR-376B-3P/HMGA2 axis is involved in pituitary tumor invasiveness Pubmed: 31899875
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPC053Hu01 Recombinant High Mobility Group AT Hook Protein 2 (HMGA2) Positive Control; Immunogen; SDS-PAGE; WB.
PAC053Hu01 Polyclonal Antibody to High Mobility Group AT Hook Protein 2 (HMGA2) WB; IHC; ICC; IP.
LAC053Hu81 FITC-Linked Polyclonal Antibody to High Mobility Group AT Hook Protein 2 (HMGA2) WB; IHC; ICC; IF.
LAC053Hu71 Biotin-Linked Polyclonal Antibody to High Mobility Group AT Hook Protein 2 (HMGA2) WB; IHC; ICC.
MAC053Hu22 Monoclonal Antibody to High Mobility Group AT Hook Protein 2 (HMGA2) WB; IHC; ICC; IP.
SEC053Hu ELISA Kit for High Mobility Group AT Hook Protein 2 (HMGA2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC053Hu Multiplex Assay Kit for High Mobility Group AT Hook Protein 2 (HMGA2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.